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Increased TRPC3 expression in vascular
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An increased expression of transient receptor potential canonical type 3 (TRPC3) cation channels has been
proposed as one of the factors contributing to the pathogenesis of hypertension. To test that hypothesis we
compared the expression of TRPC3 and TRPC6 as an endogenous control in human vascular endothelium of
preglomerular arterioles in kidney biopsies from six patients with malignant hypertension and from four
patients with diarrhea-associated hemolytic–uremic syndrome. Patients with malignant hypertension showed
significantly higher systolic blood pressure and more prominent expression of TRPC3 in vascular endothelium
of preglomerular arterioles compared to patients with hemolytic–uremic syndrome. The expression of TRPC6
was not different between the two groups. The study supports the hypothesis that the increased expression of
TRPC3 is associated with malignant hypertension in humans.
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Malignant hypertension is a hypertensive emer-
gency with severe elevation of blood pressure, a
Keith–Wagener–Barker grade III or IV hypertensive
retinopathy, and acute impairment of renal function
in most cases. In white subjects, essential hyperten-
sion accounts for approximately 30% of malignant
hypertension, whereas in blacks essential hyperten-
sion is the predominant cause, accounting for
approximately 82% of all cases. The characteristic
pathological change of malignant hypertension
represents endothelial injury. Its pathophysiology
involves mechanical stress on the vessel wall, a
proliferative endarteriitis in small arteries and
arterioles, and fibrinoid necrosis with fine suben-
dothelial droplets and hyalin thrombi formation.1,2
Recently, evidence had been obtained that an
increased expression of nonselective transient re-
ceptor potential canonical type 3 (TRPC3) cation
channels contributes to the pathogenesis of hyper-
tension. Liu et al3 reported increased TRPC3 protein
expression in spontaneously hypertensive rats
compared to normotensive Wistar–Kyoto rats.
Dietrich et al4 reported that TRPC6-deficient mice
with consecutively increased TRPC3 channel
expression developed higher blood pressure. Liu
et al5,6 and Thilo et al7 reported increased TRPC3
protein expression and increased TRPC3 transcripts
in peripheral blood monocytes from patients with
essential hypertension compared to normotensive
control subjects. The expression of TRPC3 in human
vascular endothelium has not been associated with
malignant hypertension yet. We designed this study
to test the hypothesis that the expression of TRPC3
in human vascular endothelium of preglomerular
arterioles is associated with malignant hyperten-
sion. To this end, we compared the expression of
TRPC3 in human vascular endothelium of preglo-
merular arterioles in kidney biopsies from patients
with malignant hypertension and from patients with
diarrhea-associated hemolytic–uremic syndrome.
Methods
Kidney biopsies from patients who had acute renal
insufficiency and who met the inclusion criteria
were used in this study. Kidney biopsies were
obtained from January 1998 to December 2007 and
analyzed at the Institut fu¨r Pathologie, Charite
Campus Benjamin Franklin, Berlin, Germany. The
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indication to perform a kidney biopsy was deter-
mined by each patient’s physician for evaluation of
the diagnosis of acute renal insufficiency. Informed
consent for kidney biopsies was obtained from each
patient.
Inclusion criteria comprised malignant hyper-
tension or diarrhea-associated hemolytic–uremic
syndrome. The diagnosis malignant hypertension
was verified according to the World Health Organi-
zation criteria of 1978: high blood pressure together
with bilateral linear or flame-shaped hemorrhages or
‘cotton-wool’ exudates with or without papilledema
during funduscopic examination (grade III or IV
hypertensive retinopathy, respectively, according to
the Keith–Wagener–Barker classification).2 The
diarrhea-associated hemolytic–uremic syndrome
was defined by the presence of the following.8,9
Prodromal diarrhea, microangiopathic hemolytic
anemia, ie a hemoglobin concentration below 10 g
per 100 ml and nonimmune hemolysis with frag-
mented red cells or schistocytes on a peripheral
blood smear, increased serum lactate dehydrogen-
ase, reduced serum haptoglobin, thrombocytopenia
(a platelet count of less than 150 per nl), and acute
renal insufficiency (a reduced glomerular filtration
rate less than 30 ml/min per 1.72 m2) without prior
history of chronic renal insufficiency. The period of
risk for the development of the hemolytic–uremic
syndrome was considered to be 14 days after the
onset of diarrhea according to data from the
literature.9
Exclusion criteria were pregnant women, patients
with papilledema and an intracranial hemorrhage,
patients already on dialysis before admission, or
evidence of renal parenchymal disease including
chronic glomerulonephritis, chronic pyelonephritis,
diabetic nephropathy, or tubulointerstitial disease
on histologic examination of kidney biopsies.
Patients with significant renal artery stenosis as
defined if narrowing of the renal artery lumen
exceeded 50% or patients with the diagnosis of
pheochromcytoma were excluded. Patients with a
diagnosis of thrombotic thrombocytopenic purpura
based on clinical evaluation and laboratory findings
including deficiency of the metalloprotease a disin-
tegrin and metalloprotease domain with thrombos-
pondin type1 motif13 (ADAMTS13) or inhibitory
anti-ADAMTS13 antibodies were excluded.
Immunohistochemistry
The expression of TRPC3 or TRPC6 for control
in human vascular endothelium of preglomer-
ular arterioles in kidney biopsies was analyzed
by immunohistochemistry using formalin-fixed
paraffin-embedded tissue. Sections (4 mm thick)
were cut, deparaffinized, and subjected to heat-
induced epitope retrieval step before incubation
with antibodies. For this purpose, sections were
immersed in sodium citrate buffer at pH 6.0 and
heated in a high-pressure cooker. After cooking, the
slides were rinsed in running water, washed with
Tris-buffered saline, pH 7.4 and incubated with the
primary rabbit anti-TRPC3, or rabbit anti-TRPC6
antibodies (dilution 1:1000; Alomone Labs, Jerusa-
lem, Israel) diluted in 1% bovine serum albumin in
phosphate-buffered saline. Previously published
immunoblottings from our group already confirmed
that these antibodies can be used to identify TRPC3
Table 1 Characteristics of the patients
Variable
number
Age
(years)
Sex Prodromal
diarrhea
Body mass
index
(kg/m2)
Systolic
blood
pressure
(mm Hg)
Diastolic
blood
pressure
(mm Hg)
Heart rate
(per min)
GFR (ml/min
per 1.72 m2)
Platelet
count
(per nl)
Patients with malignant hypertension
1 40 M No 27.0 200 100 72 4 104
2 45 M No 25.3 240 120 66 5 294
3 42 M No 30.4 166 90 82 42 106
4 35 M No 26.2 240 160 115 4 218
5 36 F No 22.3 200 130 84 14 155
6 40 M No 22.1 240 140 61 37 229
Median 40 — — 25.8 220* 125 77 9 186
25th–75th
percentiles
36–43 — — 22.3–27.9 191–240 98–145 65–92 4–38 105–245
Patients with hemolytic–uremic syndrome
1 58 M Yes 21.5 180 122 140 11 41
2 24 F Yes 26.0 160 85 125 5 40
3 5 F Yes 20.8 184 122 100 16 202
4 42 M Yes 26.0 130 70 88 17 76
Median 33 — — 23.7 170 104 112 13 59
25th–75th
percentiles
10–45 — — 21.0–26.0 138–184 74–125 91–136 7–17 40–171
GFR denotes estimated glomerular filtration rate according to the modification of diet in renal disease formula.
*Po0.05 for the comparison with the patients with hemolytic–uremic syndrome.
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or TRPC6 channels in human tissue.5,6 The strepta-
vidin AP kit (K5005; Dako, Glostrup, Denmark) was
used for detection and alkaline phosphatase was
developed using Fast Red as the chromogen. After
counterstaining with hematoxylin, the slides were
dehydrated and mounted. Negative controls were
performed by omitting the primary antibodies.
Intensity of TRPC3 or TRPC6 expression levels in
the human vascular endothelium of preglomerular
arterioles was scored as negative (), weak (þ ),
moderate (þ þ ), or strong (þ þ þ ). Immunohisto-
chemistry was independently evaluated by two
investigators that were unaware of the patients’
disease status and in case of discrepancy slides
were discussed over a multihead microscope until
consensus was reached.
Statistics
All data were expressed as medians and interquar-
tile ranges. The Mann–Whitney test was used to
compare data from the two groups. The null
hypothesis was rejected at Po0.05. All tests were
two sided. Analysis was performed using GraphPad
Prism version 5.00 for Windows, GraphPad Soft-
ware, San Diego, CA, USA.
Results
The clinical and biochemical characteristics of six
patients with malignant hypertension and four pa-
tients with diarrhea-associated hemolytic–uremic syn-
drome are depicted in Table 1. Systolic blood pressure
and platelet count were significantly higher in
patients with malignant hypertension than in patients
with hemolytic–uremic syndrome (Po0.05), whereas
age, body mass index, diastolic blood pressure, heart
rate, and glomerular filtration rate were not signifi-
cantly different between the two groups.
Figure 1a depicts the typical funduscopic exam-
ination of one patient with malignant hypertension
showing flame-shaped hemorrhages or ‘cotton-wool’
exudates with papilledema (grade IV hypertensive
retinopathy according to the Keith–Wagener–Barker
classification). In patients with malignant hyperten-
sion kidney biopsy revealed acute hypertensive
injury. A representative light micrograph showing
characteristic obliterative vasculopathy due to en-
dothelial damage and fibrinoid necrosis in a preglo-
merular arteriole in one patient with malignant
hypertension is depicted in Figure 1b. In patients
with malignant hypertension histologic examination
of kidney biopsies did not give evidence of renal
parenchymal disease including chronic glomerulo-
nephritis, chronic pyelonephritis, diabetic nephro-
pathy, or tubulointerstitial disease.
Now we evaluated whether elevated blood pres-
sure was associated with increased expression of
TRPC3 in human vascular endothelium of preglo-
merular arterioles using immunohistochemistry. As
indicated in Figure 2 patients with malignant
hypertension showed more prominent expression
of TRPC3 in preglomerular arterioles compared to
patients with hemolytic–uremic syndrome. We
observed a grade þ þ þ expression of TRPC3 in
five out of six patients with malignant hypertension,
and one patient with malignant hypertension
showed a grade þ þ expression of TRPC3, whereas
only two out of four patients with diarrhea-
associated hemolytic–uremic syndrome showed a
gradeþ expression and two patients showed a
grade  expression (Table 2). The expression of
TRPC6 was not different between the two groups.
Discussion
Our findings, obtained in a consecutive series of
patients who had acute renal insufficiency due to
Figure 1 (a) Representative funduscopic examination of one
patient with malignant hypertension showing flame-shaped
hemorrhages or ‘cotton–wool’ exudates with papilledema (grade
IV hypertensive retinopathy according to the Keith–Wagener–
Barker classification; arrow). (b) Representative light micrograph
showing fibrinoid necrosis (arrow) in a preglomerular arteriole in
one patient with malignant hypertension. Fibrin staining. Bar
denotes 10mm.
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malignant hypertension, supports the hypothesis
that the increased expression of TRPC3 channels in
human vascular endothelium of preglomerular
arterioles is associated with hypertension in hu-
mans. In patients with malignant hypertension
funduscopic examination showed characteristic
grade IV hypertensive retinopathy and kidney
biopsies showed characteristic obliterative vasculo-
pathy due to endothelial damage.1 The choice of
appropriate controls is important for investigations
of malignant hypertension. We compared patients
with malignant hypertension and patients with
diarrhea-associated hemolytic–uremic syndrome.
On the one hand both diseases are associated with
acute renal insufficiency and endothelial injury in
renal arterioles. On the other hand the underlying
pathogenesis is different for both diseases. In
malignant hypertension severely increased blood
pressure is the main contributing factor, whereas in
diarrhea-associated hemolytic uremic syndrome
mainly bacterial endotoxins trigger vascular in-
jury.10,11 As expected this study confirmed that
systolic blood pressure and platelet counts were
significantly higher in patients with malignant
hypertension than in patients with hemolytic–
uremic syndrome. This result is in accordance with
findings in the literature suggesting that severely
elevated systolic blood pressure (ie more than
200 mm Hg) and higher platelet counts can be
observed in patients with malignant hyper-
tension.1,11 Severely elevated systolic blood pressure
and higher platelet counts have therefore been
proposed to distinguish malignant hypertension
from diarrhea-associated hemolytic–uremic syn-
drome.11 The present finding of increased TRPC3
expression in human vascular endothelium in
patients with malignant hypertension may also
be a helpful diagnostic tool to distinguish both
diseases. No data are available yet that linked the
expression of TRPC3 in human vascular endo-
thelium of preglomerular arterioles with malignant
hypertension. We compared kidney biopsies from
patients who had acute renal insufficiency due
to malignant hypertension or diarrhea-associated
hemolytic–uremic syndrome and hence we had the
extraordinary opportunity to connect TRPC3 expres-
sion in human vascular endothelium with hyperten-
sion. Malignant hypertension is a rare disease and
its pathogenesis remains elusive. However, essential
Figure 2 Representative light micrographs and immunohistochemistry of human vascular endothelium of preglomerular arterioles in a
patient with malignant hypertension showing onion –skin changes and thickening of the intima (upper panel) and a patient with
diarrhea-associated hemolytic–uremic syndrome (lower panel). PAS, periodic acid schiff staining; TRPC3, transient receptor potential
canonical type 3; TRPC6, transient receptor potential canonical type 6. Prominent expression of TRPC3 (grade þ þ þ ) in human
vascular endothelium from the patient with malignant hypertension can be observed. Bar denotes 10 mm.
Table 2 Immunohistochemistry
Variable number TRPC3 expression TRPC6 expression
Patients with malignant hypertension
1 +++ 
2 +++ 
3 +++ +
4 ++ 
5 +++ 
6 +++ +
Patients with hemolytic–uremic syndrome
1 + +
2  
3  
4 + 
Scores can range from  to +++; higher scores indicate more severe
expression.
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hypertension appears to be an important underlying
factor. Therefore, the observation that TRPC3 ex-
pression is increased in vascular endothelium from
patients with malignant hypertension may also
indicate that an increased expression of TRPC3
channels may be important in the pathogenesis of
hypertension. Previous studies from several groups
already gave evidence for the association of TRPC3
and essential hypertension. These studies using
animal models of primary hypertension or periph-
eral blood cells from humans reported an increased
expression of TRPC3 channel transcripts, increased
TRPC3 channel proteins, and increased TRPC3
activation in hypertension.3–7 TRPC3 channels are
nonselective cation channels mediating calcium
influx. The acute calcium influx through TRPC3
channels is a key signaling mechanism that stimu-
lates the calcium-dependent release of several
endothelium-derived vasoconstrictive agents in-
cluding endothelin, urotensin, or epoxyeicosatrie-
noic acids.12–14
In conclusion for the first time we observed
direct evidence that TRPC3 expression in human
vascular endothelium is associated with malignant
hypertension.
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